Moore Matthew Richard 4
4 · Ventyx Biosciences, Inc. · Filed Jan 3, 2025
Insider Transaction Report
Form 4
Moore Matthew Richard
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-02+145,000→ 145,000 totalExercise: $2.14Exp: 2035-01-02→ Common Stock (145,000 underlying)
Footnotes (1)
- [F1]One forty-eighth (1/48th) of the total shares subject to the Option shall vest each month following the Vesting Commencement Date (as defined below) on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each such date. The Vesting Commencement Date is January 2, 2025.